Immunology Market
Immunology Market Forecasts to 2030 - Global Analysis By Drug Class (Immunosuppressants, Monoclonal Antibody, Fusion Proteins, Polyclonal Antibody and Other Drug Classes), Disease Indication, Application and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $98.93 BN |
|
Projected Year Value (2030) |
US $184.21 BN |
|
CAGR (2023 - 2030) |
9.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Immunology Market is accounted for $98.93 billion in 2023 and is expected to reach $184.21 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Immunology is the branch of biomedical science that focuses on the study of the immune system – the complex network of cells, tissues, organs, and molecules that work together to defend the body against infections and other diseases. Immunology is a dynamic and rapidly evolving field with broad applications in medicine, ranging from infectious disease management to the treatment of autoimmune conditions and cancer.
According to British Society for Immunology, in 2018, around 400,000 people in U.K are suffering with rheumatoid arthritis.
Market Dynamics:
Driver:
Increasing prevalence of immunological disorders
Genetic factors and the aging global population play a significant role in the development of many immunological disorders. Exposure to certain environmental factors, such as infections, pollutants, and toxins, may trigger or exacerbate immunological disorders. These disorders foster a competitive environment within the immunology market. It results in a larger patient population seeking medical intervention. Thereby, the increasing prevalence of immunological disorders creates a multifaceted impact on the immunology market, driving demand, innovation, and investment in research and development.
Restraint:
Strict regulations
Regulations in the immunology market are designed to ensure the safety, efficacy, and quality of products related to immunological disorders. These regulations are complex and stringent regulatory processes for the approval of immunology drugs can result in delays and increased development costs. Regulatory hurdles may limit the number of new therapies entering the market. This could further hinder the development of novel immunological therapies and limit the overall innovation in the market.
Opportunity:
Advancements in biotechnology & immunotherapy
Novel strategies for treating a range of immunological illnesses are being introduced by developments in biotechnology and immunotherapy. They make it possible to create specialised treatments that target the underlying causes of immune diseases. Moreover, personalised treatment techniques are made possible by technological breakthroughs. Alongside these important developments in immunotherapy have been cell and gene treatments. Because of these advances, the immunology market is driven by the creation of personalized medical strategies, targeted medicines, and cutting-edge treatment methods.
Threat:
Competition from biosimilars
The introduction of biosimilars, which are lower-cost alternatives to biologic drugs, can pose a threat to the market. Increased competition may lead to pricing pressures and reduced market share for originator immunology drugs. Further, the development of alternative therapies, including small molecules and gene therapies, may also pose a threat to traditional immunology drugs. These emerging therapies could offer new treatment options and potentially capture market share.
Covid-19 Impact
The covid-19 pandemic had a significant impact on the immunology market. During the pandemic, immunology research was increased to understand the effects of covid on immunity and cope with the severe effects of the same. The success of various COVID-19 vaccines has highlighted the importance of immunology in addressing global health crises, potentially leading to increased investment and interest in immunology research. Also, the emergence of new variants of the SARS-CoV-2 virus has kept the spotlight on immunology, which influenced future developments in immunology market.
The monoclonal antibody segment is expected to be the largest during the forecast period
Themonoclonal antibody segment is estimated to have a lucrative growth, due to the clinical efficiency of the procedure and the high prevalence of drugs. Monoclonal antibodies are proteins made in the laboratory for binding to specific targets in the body, such as antigens. They can enhance, restore, modify, or mimic the immune system's attack on unwanted cells. Their easy government approvals and relatively low levels of risk, is further pushing the segment expansion.
The rheumatoid arthritis segment is expected to have the highest CAGR during the forecast period
The rheumatoid arthritis segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the growing geriatric population and rising R&D. Rheumatoid arthritis is a chronic inflammatory disorder that affects joints. Rheumatoid arthritis serves as a key driver for advancements in the immunology market by providing a specific focus on immune system deregulation, leading to the development of targeted therapies, diagnostic tools, and a deeper understanding of autoimmune diseases.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to the presence of a well-established healthcare infrastructure. The region has the high prevalence of autoimmune diseases and chronic inflammatory conditions. Numerous pharmaceutical firms are actively involved in the research and marketing of immunology medications in the fiercely competitive North American market. Pfizer, Johnson & Johnson, Amgen, AbbVie, and other significant firms are doing well in this region market. Additionally, a greater diagnosis rate among patients in the area is probably going to support the expansion of the sector.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of autoimmune disorders. The region is home for several key players such as Genmab, Arctoris, Valo Therapeutics and BioNTech. Additionally, London estimates 7% of the U.K. population, or over 4 million individuals, have at least one autoimmune disorder. The region is also making efforts to secure approvals and launch drugs targeting autoimmune conditions. Thereon, the European market is driven by growing health-consciousness among consumers and boosted by the COVID-19 pandemic.
Key players in the market
Some of the key players profiled in the Immunology Market include Novartis AG, Eli Lilly and Company, AbbVie Inc., Janssen Global Services LLC, UCB SA, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Aurobindo Pharma, F. Hoffmann-La Roche Limited, Astellas Pharma Inc. and Merck Sharp & Dohme Corporation.
Key Developments:
In March 2023, Eli Lilly and Company received approval from the Indian regulatory agency Directorate General of Commercial Intelligence and Statistics (DGCI). This approval allowed them to launch their drug, Copellor, for the treatment of moderate-to-severe plaque psoriasis and also for psoriatic arthritis.
In March 2022, Pfizer Inc. enhanced its product offering by acquiring Arena Pharmaceuticals, a company dedicated to developing cutting-edge therapies for various immuno-inflammatory diseases.
Drug Classes Covered:
• Immunosuppressants
• Monoclonal Antibody
• Fusion Proteins
• Polyclonal Antibody
• Other Drug Classes
Disease Indications Covered:
• Plaque Psoriasis
• Rheumatoid Arthritis
• Prophylaxis of Organ Rejection
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Inflammatory Bowel Disease
• Other Disease Indications
Applications Covered:
• Hospital
• Clinics
• Cancer Research Centers & Institutions
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Immunology Market, By Drug Class
5.1 Introduction
5.2 Immunosuppressants
5.3 Monoclonal Antibody
5.4 Fusion Proteins
5.5 Polyclonal Antibody
5.6 Other Drug Classes
6 Global Immunology Market, By Disease Indication
6.1 Introduction
6.2 Plaque Psoriasis
6.3 Rheumatoid Arthritis
6.4 Prophylaxis of Organ Rejection
6.5 Psoriatic Arthritis
6.6 Ankylosing Spondylitis
6.7 Inflammatory Bowel Disease
6.8 Other Disease Indications
7 Global Immunology Market, By Application
7.1 Introduction
7.2 Hospital
7.3 Clinics
7.4 Cancer Research Centers & Institutions
7.5 Other Applications
8 Global Immunology Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Novartis AG
10.2 Eli Lilly and Company
10.3 AbbVie Inc.
10.4 Janssen Global Services LLC
10.5 UCB SA
10.6 Amgen Inc.
10.7 Pfizer Inc.
10.8 Bristol-Myers Squibb Company
10.9 Aurobindo Pharma
10.10 F. Hoffmann-La Roche Limited
10.11 Astellas Pharma Inc.
10.12 Merck Sharp & Dohme Corporation
List of Tables
1 Global Immunology Market Outlook, By Region (2021-2030) ($MN)
2 Global Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
3 Global Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
4 Global Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
5 Global Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
6 Global Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
7 Global Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
8 Global Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
9 Global Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
10 Global Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
11 Global Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
12 Global Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
13 Global Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
14 Global Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
15 Global Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
16 Global Immunology Market Outlook, By Application (2021-2030) ($MN)
17 Global Immunology Market Outlook, By Hospital (2021-2030) ($MN)
18 Global Immunology Market Outlook, By Clinics (2021-2030) ($MN)
19 Global Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
20 Global Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
21 North America Immunology Market Outlook, By Country (2021-2030) ($MN)
22 North America Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
23 North America Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
24 North America Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
25 North America Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
26 North America Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
27 North America Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
28 North America Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
29 North America Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
30 North America Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
31 North America Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
32 North America Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
33 North America Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
34 North America Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
35 North America Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
36 North America Immunology Market Outlook, By Application (2021-2030) ($MN)
37 North America Immunology Market Outlook, By Hospital (2021-2030) ($MN)
38 North America Immunology Market Outlook, By Clinics (2021-2030) ($MN)
39 North America Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
40 North America Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
41 Europe Immunology Market Outlook, By Country (2021-2030) ($MN)
42 Europe Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
43 Europe Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
44 Europe Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
45 Europe Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
46 Europe Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
47 Europe Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
48 Europe Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
49 Europe Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
50 Europe Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
51 Europe Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
52 Europe Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
53 Europe Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
54 Europe Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
55 Europe Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
56 Europe Immunology Market Outlook, By Application (2021-2030) ($MN)
57 Europe Immunology Market Outlook, By Hospital (2021-2030) ($MN)
58 Europe Immunology Market Outlook, By Clinics (2021-2030) ($MN)
59 Europe Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
60 Europe Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
61 Asia Pacific Immunology Market Outlook, By Country (2021-2030) ($MN)
62 Asia Pacific Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
63 Asia Pacific Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
64 Asia Pacific Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
65 Asia Pacific Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
66 Asia Pacific Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
67 Asia Pacific Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
68 Asia Pacific Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
69 Asia Pacific Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
70 Asia Pacific Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
71 Asia Pacific Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
72 Asia Pacific Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
73 Asia Pacific Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
74 Asia Pacific Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
75 Asia Pacific Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
76 Asia Pacific Immunology Market Outlook, By Application (2021-2030) ($MN)
77 Asia Pacific Immunology Market Outlook, By Hospital (2021-2030) ($MN)
78 Asia Pacific Immunology Market Outlook, By Clinics (2021-2030) ($MN)
79 Asia Pacific Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
80 Asia Pacific Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
81 South America Immunology Market Outlook, By Country (2021-2030) ($MN)
82 South America Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
83 South America Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
84 South America Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
85 South America Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
86 South America Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
87 South America Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
88 South America Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
89 South America Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
90 South America Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
91 South America Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
92 South America Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
93 South America Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
94 South America Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
95 South America Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
96 South America Immunology Market Outlook, By Application (2021-2030) ($MN)
97 South America Immunology Market Outlook, By Hospital (2021-2030) ($MN)
98 South America Immunology Market Outlook, By Clinics (2021-2030) ($MN)
99 South America Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
100 South America Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
101 Middle East & Africa Immunology Market Outlook, By Country (2021-2030) ($MN)
102 Middle East & Africa Immunology Market Outlook, By Drug Class (2021-2030) ($MN)
103 Middle East & Africa Immunology Market Outlook, By Immunosuppressants (2021-2030) ($MN)
104 Middle East & Africa Immunology Market Outlook, By Monoclonal Antibody (2021-2030) ($MN)
105 Middle East & Africa Immunology Market Outlook, By Fusion Proteins (2021-2030) ($MN)
106 Middle East & Africa Immunology Market Outlook, By Polyclonal Antibody (2021-2030) ($MN)
107 Middle East & Africa Immunology Market Outlook, By Other Drug Classes (2021-2030) ($MN)
108 Middle East & Africa Immunology Market Outlook, By Disease Indication (2021-2030) ($MN)
109 Middle East & Africa Immunology Market Outlook, By Plaque Psoriasis (2021-2030) ($MN)
110 Middle East & Africa Immunology Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
111 Middle East & Africa Immunology Market Outlook, By Prophylaxis of Organ Rejection (2021-2030) ($MN)
112 Middle East & Africa Immunology Market Outlook, By Psoriatic Arthritis (2021-2030) ($MN)
113 Middle East & Africa Immunology Market Outlook, By Ankylosing Spondylitis (2021-2030) ($MN)
114 Middle East & Africa Immunology Market Outlook, By Inflammatory Bowel Disease (2021-2030) ($MN)
115 Middle East & Africa Immunology Market Outlook, By Other Disease Indications (2021-2030) ($MN)
116 Middle East & Africa Immunology Market Outlook, By Application (2021-2030) ($MN)
117 Middle East & Africa Immunology Market Outlook, By Hospital (2021-2030) ($MN)
118 Middle East & Africa Immunology Market Outlook, By Clinics (2021-2030) ($MN)
119 Middle East & Africa Immunology Market Outlook, By Cancer Research Centers & Institutions (2021-2030) ($MN)
120 Middle East & Africa Immunology Market Outlook, By Other Applications (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
